Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype ; volume:8 ; number:1 ; day:5 ; month:2 ; year:2018 ; pages:1-9 ; date:12.2018
Scientific reports ; 8, Heft 1 (5.2.2018), 1-9, 12.2018

Keyword: Krebs
Onkologie

Creator: Wiley, Christopher D.

Contributor: Schaum, Nicholas
Alimirah, Fatouma
Lopez-Dominguez, Jose Alberto
Orjalo, Arturo V.
Scott, Gary
Desprez, Pierre-Yves
Benz, Christopher
Davalos, Albert R.
Campisi, Judith
SpringerLink (Online service)

DOI: 10.1038/s41598-018-20000-4

URN: urn:nbn:de:1111-201803272801

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Wiley, Christopher D.
Schaum, Nicholas
Alimirah, Fatouma
Lopez-Dominguez, Jose Alberto
Orjalo, Arturo V.
Scott, Gary
Desprez, Pierre-Yves
Benz, Christopher
Davalos, Albert R.
Campisi, Judith
SpringerLink (Online service)

Other Objects (12)

Hochschulschrift

Small-Molecule Inhibitors of p53-MDM2 interactions

CDK4 inhibition diminishes p53 activation by MDM2 antagonists

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials

Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists

NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation

Hochschulschrift

Small-molecule inhibitors of cyclin-dependent kinase 2 (CDK2) and the p53-Mdm2 interaction

Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction

MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer

Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway

Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity

Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition

Hochschulschrift

Small-Molecule Inhibitors of p53-MDM2 interactions

CDK4 inhibition diminishes p53 activation by MDM2 antagonists

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials

Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists

NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation

Hochschulschrift

Small-molecule inhibitors of cyclin-dependent kinase 2 (CDK2) and the p53-Mdm2 interaction

Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction

MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer

Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway

Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity

Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition

Hochschulschrift

Small-Molecule Inhibitors of p53-MDM2 interactions

CDK4 inhibition diminishes p53 activation by MDM2 antagonists

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials

Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists

NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation

Hochschulschrift

Small-molecule inhibitors of cyclin-dependent kinase 2 (CDK2) and the p53-Mdm2 interaction

Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction

MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer

Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway

Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity

Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Small-Molecule Inhibitors of p53-MDM2 interactions

CDK4 inhibition diminishes p53 activation by MDM2 antagonists

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials

Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists

NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation

Small-molecule inhibitors of cyclin-dependent kinase 2 (CDK2) and the p53-Mdm2 interaction

Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction

MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer

Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway

Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity

Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition

Small-Molecule Inhibitors of p53-MDM2 interactions

CDK4 inhibition diminishes p53 activation by MDM2 antagonists

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials

Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists

NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation

Small-molecule inhibitors of cyclin-dependent kinase 2 (CDK2) and the p53-Mdm2 interaction

Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction

MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer

Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway

Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity

Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition

Small-Molecule Inhibitors of p53-MDM2 interactions

CDK4 inhibition diminishes p53 activation by MDM2 antagonists

Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials

Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists

NMDA receptor antagonists attenuate intrathecal morphine-induced pruritus through ERK phosphorylation

Small-molecule inhibitors of cyclin-dependent kinase 2 (CDK2) and the p53-Mdm2 interaction

Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53–HDM2 Protein–Protein Interaction

MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer

Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway

Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding

Positive Modulatory Interactions of NMDA Receptor GluN1/2B Ligand Binding Domains Attenuate Antagonists Activity

Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition

Related objects

Reset password